2 Growth Stocks for In-the-Know Investors
While investors in or nearing retirement may prioritize income or security over chasing the highest returns possible, many portfolios could benefit from owning a growth stock or two. However, some of the best growth companies are the ones you've never heard about.
For instance, Tandem Diabetes Care (NASDAQ: TNDM) develops and distributes user-friendly glucose monitoring devices for individuals with type 1 and type 2 diabetes. That's not exactly the most obvious growth opportunity, but faster-than-expected adoption has the business expecting to grow revenue 94% compared to 2018.
Meanwhile, Catalent (NYSE: CTLT) and its predecessor have been manufacturing softgel drug delivery capsules since the 1930s. The business has since expanded into other drug delivery technologies, and is poised to start growing at its fastest pace in recent memory thanks to a recent acquisition in gene therapy manufacturing. Here's why these two growth stocks should be on the radars of healthcare investors.
Source Fool.com
